Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, protein aggregation-related diseases and disorders, namely, diseases caused by protein deposition, abnormal proteins, production and aggregation-related diseases and disorders, namely, amyloidosis, and neurodegenerative diseases and disorders.
REGISTERED
on 04 Oct 2024
KLIRFIBA
ALEXION PHARMACEUTICALS INC.
2183970 · 07 Apr 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, protein aggregation-related diseases and disorders, namely, diseases caused by protein deposition, abnormal proteins, production and aggregation-related diseases and disorders, namely, amyloidosis, and neurodegenerative diseases and disorders.
Pharmaceutical preparations for the treatment of autoimmune diseases a...
